advertisement

---

Vingerling JR 4

Showing records 1 to 4 | Display all abstracts from Vingerling JR

47734 Defining glaucomatous optic neuropathy from a continuous measure of optic nerve damage the optimal cut-off point for risk-factor analysis in population-based epidemiology
Ramdas WD; Rizopoulos D; Wolfs RCW; Hofman A; de Jong PTVM; Vingerling JR; Jansonius NM
Ophthalmic Epidemiology 2011; 18: 211-216

---

48301 Visual impairment and quality of life in the older European population, the EUREYE study
Seland JH; Vingerling JR; Augood CA; Bentham G; Chakravarthy U; deJong PT; Rahu M; Soubrane G; Tomazzoli L; Topouzis F
Acta Ophthalmologica 2011; 89: 608-613

---

47733 Heidelberg Retina Tomograph (HRT3) in population-based epidemiology: Normative values and criteria for glaucomatous optic neuropathy
Ramdas WD; Wolfs RCW; Hofman A; de Jong PTVM; Vingerling JR; Jansonius NM
Ophthalmic Epidemiology 2011; 18: 198-210

---

47980 Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study
Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Investigative ophthalmology & visual science 2011; 52: 6875-6881

---